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Overpopulation of free-roaming cats is a major problem leading to negative impacts
on animal health and welfare, public nuisance, transmission of zoonotic diseases, and
well-documented harm to wildlife. Surgical sterilization had failed to provide a practical
solution to free-roaming cats’ overpopulation under field conditions; therefore, efficient
and safe non-surgical immunocontraception methods are aspired. Rabies is a deadly
virus that may infect people and animals. However, the safety and efficacy of combined
vaccination with anti-GnRH and rabies vaccines in feral cats, which often suffer from
disrupted health conditions and experienced high stress level, has never been studied.
Therefore, our objective was to examine the short-term safety and efficacy of anti-GnRH
vaccine (Gonacon), in combination with rabies vaccine in female feral cats. Mature feral
female cats were captured and divided into the following groups: (I) GonaconX1-Rabies:
queens vaccinated with both Gonacon and rabies (n = 5); (II) GonaconX2-Rabies:
queens vaccinated twice with Gonacon (3 weeks apart) and with Rabies (n = 4);
(III) OVx-Rabies: queens ovariohysterectomized and vaccinated with rabies (n = 4);
(IV) Intact-Rabies: queens vaccinated against rabies and remained intact (n = 3).
Comprehensive veterinary examinations and blood tests were performed every 2 weeks
for 14 weeks. Data were analyzed by Repeated-Measures-ANOVA or Fisher-Exact-Test.
There were neither systemic nor local adverse reactions at the vaccination sites. Blood
count (PCV, TS, RBC, HGB, HCT, WBC) and chemistry (Total protein, Total globulin,
Albumin, Urea, Creatinine, Creatine kinase, Bilirubin, GGT, ALT, AST) analyses revealed
no differences among groups. There were no differences in serum rabies antibodies
titers among groups, and queens kept a protective titer (>0.5 IU/mL) starting at 2–4
weeks after vaccination. Anti-GnRH antibodies were detected in all Gonacon-vaccinated
queens, excluding one queen (GonaconX2-Rabies group). Anti-müllerian hormone
serum concentrations reduced significantly after ovariohysterectomy, as well as
gradually following vaccination with Gonacon, but it remained high in intact queens.
Novak et al. Immunocontraception-Rabies Vaccination of Feral Cats
Evaluation of vaginal cytology and ovarian histology suggested that reproductive cyclicity
was suppressed in Gonacon-vaccinated queens. Our results support the conclusion
that in the short term, the combined vaccination with Gonacon and rabies is safe and
effective in female feral cats. However, further long-term studies are warranted to test
this immunologic regimen in feral cats.
Keywords: feral cats, anti-GnRH vaccine, Gonacon, non-surgical contraception, contraception, sterilization,
rabies
INTRODUCTION
Overpopulation of free-roaming cats is a global problem in both
urban and rural societies (1). It negatively impacts the cats’
welfare and health (starvation, diseases, run over by cars, etc.),
as well as causing public health risks due to the transmission
of zoonotic diseases to humans (e.g., toxoplasmosis, rabies, cat
scratch disease, leptospirosis, Q fever, toxocariasis, flea-borne
typhus, etc.); some of these are reported to cause important
health issues including abortion, blindness, pruritic skin rashes
and other various symptoms, as well as mortality (2–6). Free-
roaming abandoned and feral cats are non-native predators; they
cause substantial wildlife destruction and ecosystem disruption,
including the deaths ofmillions of birds, small mammals, reptiles,
amphibians, and fish (7). Furthermore, disease transmission from
cats to livestock and wild animals, attacks on humans, traffic
accidents, and nuisance behavior, are just part of many concerns
involved with this matter (6, 8, 9). Currently, surgical sterilization
(ovariohysterectomy; orchiectomy) is the most common practice
to control free-roaming cat reproduction, mainly via “Trap-
Neutering-Return” (TNR) programs. It provides a permanent
solution, should be done only once, and may positively affect
the health and welfare of individual feral cats (10). However,
the surgical approach is expensive, and requires surgical and
anesthetic materials, equipment, as well as skilled veterinarians.
Furthermore, it may cause significant stress to the animals (9, 11,
12). Therefore, the surgical approach practically failed to provide
a solution for the millions of free-roaming cats that are confined
and euthanized annually (9, 13–15). An efficient non-surgical
sterilization/contraception method could have a significant
impact on the control of cat overpopulation. However, to the best
of our knowledge, despite significant efforts over the several last
decades, there are currently no efficient commercial products that
can be used for mass non-surgical sterilization/contraception of
free-roaming cat populations (15, 16).
Rabies is a deadly, vaccine-preventable, zoonotic, viral disease,
which may infect people and animals (17). According to the
World Health Organization report (updated in April 2020), most
Abbreviations: AMH, Anti-müllerian hormone; LH, Luteinizing hormone;
FSH, follicle-stimulating hormone; GnRH, Gonadotropin-releasing hormone;
PCV, Packed cell volume; RBC, red blood cell count; MCV, mean corpuscular
hemoglobin; MCH, mean corpuscular hemoglobin concentration; MCHC,
mean corpuscular hemoglobin concentration; CHCM, cell hemoglobin
concentration mean; CH, cellular hemoglobin; RDW, red cell distribution
width; HDW, hemoglobin distribution width; WBC, white blood cells count;
LUC, large unstained cells; ALT, alanine aminotransferase; GGT, gamma-glutamyl
transpeptidase; AST, aspartate aminotransferase.
human cases worldwide are due to disease transmission from
domestic dogs. However, mandatory dog vaccination programs
have halted the natural spread of rabies among domestic dogs
in many countries. According to the information from the USA
Centers for Disease Control and Prevention (CDC; updated on
April 2020), as well as from other reports (4, 18, 19), in the USA,
cats have become the companion animal species most commonly
reported as rabid. Accordingly, in many endemic countries,
including Israel and the USA, combined animal reproduction
control and rabies vaccination programs are aspired.
Reproduction in the domestic queens is affected by
photoperiod, as this species is considered as seasonal,
polyestrous, long day breeder, with multiple ovulations
induced following vaginal stimulation during mating (20, 21).
Gonadotropin-Releasing Hormone (GnRH), which is released
from the hypothalamus, is the master hormone of reproduction;
it controls steroidogenesis and gametogenesis by stimulating
the release of the pituitary gonadotropins, luteinizing hormone
(LH) and follicle-stimulating hormone (FSH), triggering a
cascade of endocrine effects that lead to sperm production in
males and follicular development and ovulation in females.
Gonacon is an anti-GnRH vaccine, developed by the National
Wildlife Research Center, USDA APHIS Wildlife Services, USA.
This immunocontraceptive vaccine was designed to trigger the
production of antibodies that neutralize GnRH. It has been tested
in many species, including white-tail deer (22), elk (23), horses
(24, 25), cattle (26), ferrets (27), domestic, and wild pigs (28), as
well as to a limited extent in dogs (29) and cats (30–33). However,
none of the four previous studies conducted on cats included
measurements of rabies antibodies in Gonacon-vaccinated cats,
even in the studies in which cats were vaccinated with both
vaccines (32, 33). Furthermore, in previous Gonacon studies
conducted on cats, animals were not feral cats; they were either
specific-pathogen-free (SPF) laboratory cats (30, 31), cats from
research colony (32), or well-maintained friendly cats obtained
from animal control agencies or from private individuals who
posted cats for rehoming (33). All cats were kept in excellent
health and body conditions, and were accustomed to human
interactions. However, many previous reports documented
that feral cats often suffer from high rates of morbidity and
pre-mature mortality due to infectious (e.g., FIV, FeLV, parasites)
and non-infectious diseases, malnutrition, poor body condition,
traumas, etc. (9, 10, 34–36). Furthermore, most of these cats are
typically too fearful and too wild to be handled awake, as they
are not accustomed to close interactions with people. Therefore,
feral cats, which are the main target population for non-surgical
contraception/sterilization, often suffer from acute and chronic
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health problems and are under chronic stress due to their
lifestyle and environment (5, 9, 10, 34–36). Potentially, these
suboptimal conditions might weaken the immune response and
antibody production following vaccination, such as to Gonacon
and rabies vaccines, as has been documented for other vaccines
and species (37–42). As recently reviewed by Zimmermann and
Curtis (41), several factor might affect the immune respond and
antibody production of individuals following vaccination; these
include age, sex, genetics, comorbidities, infections, parasites,
microbiota, pre-existing immunity, acute and choric stress, body
condition, nutritional status, micronutrients (vitamins A, D,
and E and zinc), as well as environmental factors, and vaccine
factors (vaccine type, product, strain, and batch; vaccination
route; combinations of vaccines, cet.). For example, some studies
indicated poorer humoral response to influenza vaccine in
humans with chronic diseases (37); Chronic inflammatory
processes like rheumatoid arthritis alter the immune system and
antibody formation (43); furthermore, depression and dementia
as well as psychological stress are associated with poor antibody
response and a higher range of inflammation markers (44).
Thus, vaccines should optimally be tested in the typical target
population and conditions.
Therefore, the objective of the current study was to examine
the short-term safety and efficacy of the anti-GnRH vaccine
(Gonacon), given either as a single dose, or two doses 3 weeks
apart, in combination with rabies vaccine, in mature feral female
cats. Our main hypotheses were that: (1) in the short term
(14 weeks), the combined vaccination with Gonacon and rabies
will not be harmful and will not have adverse side effects; (2)
antibody titers against GnRH and rabies will increase following
the combined vaccination; (3) as compared to a single dose
Gonacon vaccination, two doses of Gonacon given 3 weeks
apart (booster) will induce higher anti-GnRH titer, but anti-
rabies antibodies titer will not differ; (4) development of anti-
GnRH antibodies will be associated with suppression of the
ovarian function; and (5) antibody titers against rabies will not be
negatively influenced by the simultaneous vaccination approach
and will remain protective during the study period.
MATERIALS AND METHODS
Cats, Housing, and Handling
The study was conducted according to the ethical approval
of the Hebrew University’s Institutional Animal Care and Use
Committee (IACUC MD-17-14613-2). As part of the trap-
neuter-return (TNR) program in a large city in Israel (Be’er-
Sheva), free-roaming feral domestic short-hair (DSH) queens
were captured by professional trappers using commercial traps,
and were transported to the cats’ housing facility located at the
municipal veterinary department. Mature intact queens (n = 16;
estimated age ranged from 1 to 3 years), with no severe injuries,
were randomly selected for the study, which was conducted
during the natural breeding season of cats in Israel (July to
September). During the 14-weeks study, queens were housed
individually in cages in the same ventilated room andmaintained
at ambient temperature and light. They could see and smell
each other, without direct contact. Food and water were available
ad libitum, and environmental enrichment was provided in
each cage.
Queens were observed by professional veterinarians and staff,
at least twice every day during the 14-weeks study period. The
attitude, appetite, and alertness of the queens were evaluated
while the cats were in their cages. However, these queens could
not be handled safely while awake, as they were not friendly and
not used to any human contact (typical for most free-roaming
cats in Israel). Therefore, full physical examinations, treatments,
and sampling (blood and vaginal smears) were performed under
heavy sedation. Every 2 weeks, starting at the vaccination day,
the queens were sedated using a combination of Medetomidine
(0.02–0.04mg/kg; Orion Pharma, Finland), Butorphanol (0.2–0.4
mg/kg; intramuscular injection; Richter Pharma AG, Austria),
and Midazolam (0.1–0.25 mg/kg intramuscular injection; Rafa
laboratories, Israel). At the end of the procedure, Medetomidine
was reversed by subcutaneous administration of atipamezole
(0.05–0.10 mg/kg; Orion Pharma, Finland). After the study was
completed, cats that had relatively calm temperaments were
acclimated, and thereafter were adopted. Others were released
back to the exact location in which they were initially trapped,
in compliance with the Israeli Feral Cat Low. All queens were
in good health and body condition at the time of adoption
or release.
Treatments and Study Design
At study initiation, queens were allocated into one of the
following groups: (I) GonaconX1-Rabies: queens were vaccinated
with both Gonacon and rabies vaccines (n= 5); (II) GonaconX2-
Rabies: queens were vaccinated twice with Gonacon (at study
initiation, and again 3 weeks later) and once with rabies vaccine,
at study initiation (n = 4); (III) OVx-Rabies: queens underwent
surgical ovariohysterectomy and vaccinated against rabies at
study initiation (n = 4); (IV) Intact-Rabies: queens vaccinated
against rabies and remained intact (n = 3). Vaccination against
rabies was performed at study initiation in all queens by
subcutaneous administration of a commercial rabies vaccine
(Rabisin, Merial, France) at the left thigh. Vaccination with
Gonacon was performed by intramuscular administration of
vaccines provided by USDA-APHIS NWRC (Fort Collins,
CO, USA). The Gonacon vaccine was injected into the right
quadriceps muscle group. Before the administration of the
vaccines, the fur was clipped, and the injection sites were cleaned
with 70% isopropyl alcohol.
Monitoring and Sampling
Throughout the study, queens were monitored daily for their
attitude, appetite, and alertness. Every 2 weeks, for a total period
of 14 weeks, full physical examinations were performed by a
certified veterinarian, including also evaluation of body condition
on a 5-point scale (45), examinations of the injection sites,
as well as collections of vaginal smears. Furthermore, blood
samples were collected by jugular venipuncture every 2 weeks
into potassium-EDTA tubes, as well as into plain tubes containing
no anticoagulant. Blood samples in potassium-EDTA tubes were
stored at 4◦C and used for complete blood count (CBC) analysis
within 4 h. Blood in plain tubes was allowed to clot, centrifuged,
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and serum samples were stored at −80◦C until analyses at
study completion, which included serum chemistry, anti-GnRH
and anti-rabies antibody titer, serology for FIV and FeLV, as
well as analysis of serum Anti Müllerian Hormone (AMH)
concentration. At study termination, all queens underwent
surgical ovariohysterectomy, except the cats in the OVx-Rabies
group, in which ovariohysterectomy was performed at study
initiation. The removed reproductive tracts from all queens were
kept and processed for histological evaluation, as detailed below.
Complete Blood Count and Blood
Chemistry Analyses
Blood samples collected in potassium-EDTA tubes on weeks
0, 2, 4, 6, 8, 10, 12, and 14 were used for complete blood
count (CBC; Advia 2120, Siemens, Erfurt, Germany). Packed
cell volume (PCV) was measured routinely, using a hematocrit
tube sealed with clay that was centrifuged for ∼3min; plasma
total solids was measured by placing the plasma directly onto
a refractometer (Clinical Refractometer RHC-200 ATC, Cmall,
Medent, Israel). Blood smears were prepared and stained by
automatic slide Stainer with amodifiedWright’s staining solution
(Modified Wright’s Stain, Bayer Hematek 2000 Slide Stainer,
Siemens, Elkhart, IN, USA), and used for microscopic evaluation
of blood cells. Neutrophil cytoplasmic toxicity was evaluated
microscopically as previously described (46), by an experienced
observer who was blinded to the identity of the queens and
treatments (Dr. Nivi, DVM, Dip.ECVIM-CA).
Serum samples collected on weeks 0, 2, 8, and 14 were
used for chemistry analysis (Cobas Integra 400 Plus; Roche,
Mannheim, Germany, at 37◦C). The analysis included the
following parameters: Urea, Creatinine, Albumin, Alanine
Amino-Transferase (ALT), Aspartate Amino-Transferase (AST),
Gamma-Glutamyl Transpeptidase (GGT), Bilirubin, Creatine
Kinase (CK), Globulins, and Total protein (TP).
Detection of GnRH Antibodies
Serum samples were sent frozen to USDA-APHIS NWRC and
were analyzed for GnRH antibodies using an Enzyme-Linked
Immunosorbent Assay, as previously described (31). Serum
samples were diluted in two-fold series from 1:8,000 to 1:64,000
in phosphate-buffered saline (PBS) and run in duplicate. A
positive control sample was also run in duplicate on each plate.
The cutoff values for each plate were generated from the pre-
vaccination samples from all animals at each dilution as the mean
+ 3SD. The %CV for the positive control samples at each dilution
was low, demonstrating little inter-plate variability (1:8,000, 7.3%;
1:16,000, 5.9%; 1:32,000, 8.2%, 1:64,000, 11.2%).
Detection of Anti-Rabies Antibodies
Serum samples collected on weeks 0, 2, 4, 6, 8, 10, 12, and 14
were analyzed for anti-Rabies antibodies concentrations using
Rapid Fluorescent Focus Inhibition Test (RFFIT), as previously
described (47), in the OIE-accredited laboratory of Dr. Boris
Yakobson at the KimronVeterinary Institute (Veterinary Services
and Animal Health, Israel). The RFFIT assay has been shown to
have a sensitivity and specificity of 100 and 89%, respectively,
and is considered as the gold standard by the World Health
Organization (47, 48). Briefly, titers were recorded as serial
dilutions with positive and negative control samples. All serum
dilutions were addedwith an equal volume of virus and incubated
at 37◦C in a controlled humidity carbon dioxide 0.5% chamber
for 90min. Then, a suspension of 1 × 105 cells (MNA-Mouse
neuroblastoma, CDC USA, Wistar Institute, Philadelphia, USA)
in 0.2mL of growth medium (MEM EAGLE, with fetal bovine
serum, vitamin solution concentrated, L-Glutamine, Sodium
Bicarbonate, Penicillin G, Streptomycin and Amphotericin B;
Biological Industries, Israel) was added to each well, and the
chamber was returned to incubation for 20 h. Thereafter, the
growth medium was removed, the chambers were rinsed in
phosphate-buffered saline (PBS), and the cells were fixed with
cold acetone (−20◦C) at room temperature for 10min. FITC
anti-rabies conjugate (Fujirebio, USA) was added, and the
chamber was incubated for 30min in a humidity incubator
(37◦C), and finally washed with PBS. The slides were examined
with a microscope (Olympus BX40, 470 excitation wavelength,
×200 magnification). Each well was divided into 20 fields, and
the number of fields containing fluorescent cells was tabulated
(49). Serological titers were converted to international units per
mL (IU/mL). A titer value of >0.5 IU/mL was considered as a
protective antibody level (47).
Serum Anti Müllerian Hormone Analysis
Serum anti-Müllerian hormone (AMH) concentrations were
analyzed in samples from weeks 0, 8, and 14 using an Enzyme-
Linked Immunosorbent Assay kit (AMHGen II ELISA; Beckman
coulter, Inc. Brea, CA, USA) according to the manufacturer’s
instructions and as previously described and validated for cats
(50). Briefly, 300 µL of AMH Gen II Assay Buffer were mixed
with 60 µL of calibrator, control, or sample, and 120 µL from
the mix were pipetted into the wells in the plate, in duplicates.
After incubation and washing, 100 µL of anti-AMH biotin
conjugate was added to each well. After a second incubation
and washing, 100 µL of the streptavidin-enzyme conjugate were
added. Following a third incubation and washing step, 100
µL of TMB chromogen solution were added, followed by the
final addition of 100 µL of an acidic stopping solution. The
degree of enzymatic turnover of the substrate was determined
by using a microplate reader (SpectraMax ParadigmMulti-mode
detection platform, Molecular Devices, Austria) using dual-
wavelength absorbance measurement at 450 and 620 nm. The
inter- and intra- coefficient of variations (%CV) were 5.4 and
4.2%, respectively.
Vaginal Cytology
A fine cotton swab was used to obtain cells from the cranial
vagina, which were spread on glass slides, as previously described
(51). Slides were stained with Diff-Quick, and were evaluated
microscopically (1,000× magnification. Primo Star, Carl Zeiss,
Germany) by a single experienced observer, who was blinded to
the origin of the slides and the status of the queens. For each Diff-
Quick stained slide, >200 epithelial vaginal cells were classified
as parabasal, intermediate or superficial (nucleate and anucleate)
cells (52). If >60% of the vaginal cells were superficial cells, the
queen was considered to be in proestrus/estrus.
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Ovarian and Uterine Histology
Ovaries and uterine tissues collected during
ovariohysterectomies were fixed immediately after collection
in Bouin’s solution for 24 h at 4◦C, and then were moved to
70% ethanol. Tissues were embedded in paraffin, sectioned
(4µm thickness), and stained with hematoxylin and eosin
(H&E; Sigma-Aldrich, Israel). Histological evaluation of
these sections was performed using a light microscope (Axio
Imager M1, AxioCam HRc camera; Carl Zeiss, Germany). In
the ovary, we subjectively assessed the general morphology
and presence of primordial follicles, antral follicles, corpora
lutea, and oocytes; in the uterus, we assessed the general
structural layers, as well as the competence of the luminal
epithelium, and morphology of the endometrial glands within
the endometrium.
FIV/FeLV Serology
As part of the evaluation of the cats’ health, serum samples
collected prior to vaccination (week 0) were analyzed to detect
antibodies for Feline immunodeficiency virus (FIV) and Feline
leukemia virus (FeLV), using FIV/FeLV antibody commercial
test kit (SNAP∗ Combo plus, IDEXX, USA), according to the
manufacturer’s instructions.
Statistical Analysis
Statistical analyses were performed using Statistix 8 software
(Analytical Software, Tallahassee, FL USA); plots were produced
by Prism 5.01 (GraphPad Software; San-Diego, CA, USA).
Continuous data were analyzed by Repeated-Measures-ANOVA,
to evaluate the effects of Group (between-subject factor),
Time (within-subject factor), and Group-by-Time interactions,
FIGURE 1 | Body condition score and the vital signs of cats in the research groups. Mean ± SEM of temperature, pulse, respiratory rate, and body condition score
are presented for each group: GonaconX1-Rabies: cats vaccinated with both Gonacon and Rabies (n = 5); GonaconX2-Rabies: cats vaccinated twice with Gonacon
(3 weeks apart) and with rabies (n = 4); OVx-Rabies: cats ovariohysterectomized and vaccinated with rabies (n = 4); Intact-Rabies: cats vaccinated against rabies and
remained intact (n = 3). Parameters were collected every 2 weeks for a total of 14 weeks, while cats were under heavy sedation. Dotted lines indicate normal limits.
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followed by Tukey HSD All-Pairwise Comparisons Test. When
was applicable, two groups were compared by Wilcoxon Rank
Sum Test. Fisher-Exact-Test was used to compare proportional
data. Differences were considered significant at P < 0.05. Unless
otherwise noted, results are presented as mean± SEM.
RESULTS
Physical Examinations, Complete Blood
Count, and Blood Chemistry Analyses
During the course of the study, no swelling, signs of
inflammation, or tenderness were detected at the injection sites,
in any of the queens. All queens were in fair to good physical
condition, and had a normal attitude and appetite. Vital signs
(TPR; Temperature, Pulse, and Respiratory rates) remained
within normal ranges, with no significant differences among the
groups or over time (Figure 1). Body condition score (BCS) did
not differ among the groups, but overall, it improved over the
study period (p= 0.0281); BCS of individual cats stayed the same
or increased by up to one point in a 5-point BCS scale (45).
Complete blood count (CBC) was completed for all
the samples (8 samples for each cat). There were no
significant differences among the groups in all the CBC
parameters (Figures 2, 3). However, in some individuals, some
of the parameters were abnormal at study initiation, mainly
indicating mild anemia or inflammatory condition, but they
improved over the study period, and were within normal
limits later on. Accordingly, there were significant differences
along time (Repeated Measure ANOVA; p < 0.05) in the
following parameters; PCV, TS, RBC, Hemoglobin, HCT,
MCH, MCV, HDW, CH, WBC, Neutrophils, Lymphocytes, and
Large unstained cells (LUC, which are activated lymphocytes
and peroxidase-negative cells). In addition, overall, signs of
neutrophil toxicity were common at study initiation, but were
absent at study completion (6/16, 38% vs. 0/16, 0%; p = 0.0177).
Analyses of blood chemistry parameters were conducted on
blood samples from weeks 0, 2, 8, and 14, to overall estimate
the function of internal organs, such as liver and kidney, after
vaccination. As illustrated in Figure 4, there were no significant
differences among the groups at the chemistry parameters,
except for a few parameters, at study initiation, before the
queens were vaccinated; mean AST and CK concentrations were
significantly high at the GonaconX1 group, and ALT was high
in both GonaconX1-Rabies and Intact-Rabies groups (p < 0.05).
However, all parameters improved over the study period, and
were within normal limits later on, excluding albumin and total
proteins, which were relatively low throughout the study.
None of the queens in the study had positive serology for
FeLV; however, one queen in the GonaconX1-Rabies group was
positive for FIV.
GnRH Antibodies
There were significant effects of the group, the time, and the
group X time interaction on the anti-GnRH antibody titer
(p ≤ 0.0003; Figure 5). As expected, anti-GnRH antibodies
were not detected in any the control queens (OVx-Rabies
and Intact-Rabies groups). However, following vaccination
with Gonacon, anti-GnRH antibodies titer increased in all
vaccinated queens (GonaconX1-Rabies and GonaconX2-Rabies
groups), except for one queen (cat #9) from the GonaconX2-
Rabies group, in which no anti-GnRH antibodies could not
be detected in any of its serum samples (Figure 6). There
was no significant difference between the GonaconX1-Rabies
and GonaconX2-Rabies groups (p = 0.4943). In all responder
queens, positive anti-GnRH antibody titers were detected,
typically within 2 or 4 weeks, and remained high during the
study period; except for one queen from the GonaconX1-
Rabies group (cat #4), in which antibodies decreased in
the last two samples. This queen was identified later on
as FIV positive.
Rabies Antibodies
There were no significant differences in the anti-rabies antibodies
among groups (p = 0.3169), or group X time interaction (p
= 0.7220); however, time was a significant factor (p < 0.0001;
Figure 7). Following vaccination with rabies, all queens from all
the groups produced antibodies against rabies, which remained
above 0.5 IU/mL throughout the study, a titer that is considered
protective. Typically, the anti-rabies antibodies titer peaked at 4–
8 weeks following vaccination, and then gradually reduced and
appeared to be stabilized.
Anti-müllerian Hormone Serum
Concentrations
As illustrated in Figure 8, AMH serum concentrations reduced
significantly after ovariohysterectomy (p = 0.0023), but it
remained high in intact queens (p = 0.4174). In queens
vaccinated with Gonacon, the reduction in AMH concentration
was gradual (p = 0.0006). In all Gonacon-vaccinated queens,
AMH serum concentrations were lower at study completion,
as compared to study initiation, except in the non-responder
queen in the GonaconX2-Rabies, who kept relatively stable AMH
concentrations. In the GonaconX1-Rabies group, mean AMH
concentration was significantly lower at study completion, as
compared to study initiation (p = 0.0081). In the GonaconX2-
Rabies group, mean AMH concentration was not statistically
different at study completion (p = 0.1257); however, when the
data of the non-responder queen was excluded from the analysis,
the difference in AMH concentrations between study initiation
and study completion was significant also in that group (p
= 0.0178).
Vaginal Cytology
The analysis of the percentage of superficial cells in vaginal
cytology smears by Repeated Measure ANOVA revealed no
significant effect of the group (p = 0.6286), time (p = 0.4027),
and group X time interaction (p = 0.4804). None of the queens
in the Ovx-Rabies group had cytological signs of estrus/proestrus
(i.e., >60% superficial cells) after ovariohysterectomy, while in
the intact-Rabies group, two out of three queens showed such
cytological signs. Interestingly, none of the Gonacon-vaccinated
queens had signs of proestrus/estrus in the last 2 weeks of the
study, excluding the non-responder queen in the GonaconX2-
Rabies group. Furthermore, overall, among the cytology slides
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FIGURE 2 | Red blood cells parameters of cats in the research groups. Mean ± SEM of red blood cells parameters are presented for each group:
GonaconX1-Rabies: cats vaccinated with both Gonacon and rabies (n = 5); GonaconX2-Rabies: cats vaccinated twice with Gonacon (3 weeks apart) and with rabies
(n = 4); OVx-Rabies: cats ovariohysterectomized and vaccinated with rabies (n = 4); Intact-Rabies: cats vaccinated against rabies and remained intact (n = 3). Blood
samples were collected every 2 weeks for a total of 14 weeks. Dotted lines indicate normal limits. PCV, packed cell volume; RBC, red blood cell count; MCV, mean
corpuscular hemoglobin; MCH, mean corpuscular hemoglobin concentration; MCHC, mean corpuscular hemoglobin concentration; CHCM, cell hemoglobin
concentration mean; CH, cellular hemoglobin; RDW, red cell distribution width; HDW, hemoglobin distribution width.
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FIGURE 3 | White blood cells parameters of cats in the research groups. Mean ± SEM of white blood cells parameters are presented for each group:
GonaconX1-Rabies: cats vaccinated with both Gonacon and rabies (n = 5); GonaconX2-Rabies: cats vaccinated twice with Gonacon (3 weeks apart) and with rabies
(n = 4); OVx-Rabies: cats ovariohysterectomized and vaccinated with rabies (n = 4); Intact-Rabies: cats vaccinated against rabies and remained intact (n = 3). Blood
samples were collected every 2 weeks for a total of 14 weeks. Dotted lines indicate normal limits. WBC, white blood cells count; LUC, large unstained cells.
obtained from Gonacon-vaccinated cats, the percentage of
superficial cells in the smear was significantly lower when the
anti-GnRH titer was high (titer 0, 43.7± 8.7%, vs. titer 1:64, 10±
1.9%; p= 0.0135).
Histology of the Reproductive Tract
Histologic evaluation of the ovaries collected from Gonacon-
vaccinated cats demonstrated many degenerative oocytes, and no
to only a few very small antral follicles (Figure 9). In contrast,
ovaries of cats that were not vaccinated with Gonacon had
normal histology, with various follicles (primary, secondary, and
antral follicle), and very few degenerative oocytes. The ovaries
of the non-responder cat from the GonaconX2-Rabies were
similar to that of non-Gonacon- vaccinated controls cats, with
obvious large antral follicles, compatible with estrus. There were
no apparent differences between Gonacon-vaccinated cats to
controls in the shape, morphology, or amount of the crowded
primordial follicles under the ovary’s tunica albuginea, at the
ovarian cortex. Furthermore, no obvious difference could be
observed in the endometrium of Gonacon-vaccinated cats vs.
controls (data not shown).
DISCUSSION
The rationale of this study was to examine the short-term safety
and efficacy of combined vaccination with anti-GnRH (Gonacon)
and rabies vaccines, specifically in female feral cats, which often
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FIGURE 4 | Blood chemistry parameters of cats in the research groups. Mean ± SEM of blood chemistry parameters are presented for each group:
GonaconX1-Rabies: cats vaccinated with both Gonacon and rabies (n = 5); GonaconX2-Rabies: cats vaccinated twice with Gonacon (3 weeks apart) and with rabies
(n = 4); OVx-Rabies: cats ovariohysterectomized and vaccinated with rabies (n = 4); Intact-Rabies: cats vaccinated against rabies and remained intact (n = 3).
Analyses were performed on blood samples collected at 0, 2, 8, and 14 weeks after the initial vaccination. Dotted lines indicate normal limits. ALT, alanine
aminotransferase; GGT, gamma-glutamyl transpeptidase; AST, aspartate aminotransferase.
Frontiers in Veterinary Science | www.frontiersin.org 9 May 2021 | Volume 8 | Article 650291
Novak et al. Immunocontraception-Rabies Vaccination of Feral Cats
FIGURE 5 | Serum GnRH antibodies titer of cats in the research groups. Mean ± SEM GnRH titers are presented for each group: GonaconX1-Rabies: cats
vaccinated with both Gonacon and rabies (n = 5); GonaconX2-Rabies: cats vaccinated twice with Gonacon (3 weeks apart) and with rabies (n = 4); OVx-Rabies: cats
ovariohysterectomized and vaccinated with rabies (n = 4); Intact-Rabies: cats vaccinated against rabies and remained intact (n = 3). Blood samples were collected
every 2 weeks for a total of 14 weeks. There were significant effects of the group, the time, and the group X time interaction on the anti-GnRH antibodies titer
(Repeated measure ANOVA, p ≤ 0.0003). Variability within each group was extremely small, and therefore the SEM are unnoticeable.
suffer from disrupted health conditions and experience high-
stress levels, which potentially may alter vaccination efficacy.
Our study indicated that in the short term, the combined
vaccination with Gonacon and rabies is safe and effective in
female feral cats, with no apparent benefits for two Gonacon
vaccinations as compared to a single dose. Over the study period,
no local or systemic adverse health concerns were detected, in
accordance with our hypothesis. There were no differences in
serum rabies antibody titers among groups, and queens kept
a protective titer throughout the study. Anti-GnRH antibodies
were detected in all Gonacon-vaccinated queens, excluding
one queen (GonaconX2-Rabies group). Furthermore, evaluation
of serum AMH concentrations, vaginal cytology, and ovarian
histology suggested that reproductive cyclicity was indeed
suppressed in Gonacon-vaccinated queens, as hypothesized.
Different from previous studies in which researchers
examined the effects of Gonacon in experimental cats or pets
cats from colonies, in the current study we utilized feral cats.
In previous Gonacon studies (30–33), animals were domestic
short hair cats kept in excellent health and body conditions,
and were accustomed to human interactions. In the studies
of Levy et al. (30, 31), specific-pathogen-free (SPF) males
and females, respectively, were acquired from a commercial
vendor and housed in climate-controlled indoor spaces with
controlled light cycles (30, 31). Vansandt et al. (32) used
ovariohysterectomized cats from a research colony at the
Cincinnati Zoo and Botanical Garden’s Center for Conservation
and Research of Endangered Wildlife. In the study conducted by
Fischer et al. (33), well-maintained friendly cats were obtained
from animal control agencies, or from private individuals who
posted cats for rehoming on a classified advertisement website;
all cats were in excellent body condition and health. However,
it is well-documented that feral cats often suffer from high
rates of pre-mature mortality and morbidity due to infectious
and non-infectious diseases, internal and external parasites,
starvation and poor body condition, weather extremes, trauma,
etc. (9, 10, 34–36). Furthermore, most of these cats are not
accustomed to contact with people and are typically too fearful
and too wild to be handled. Therefore, feral cats often suffer from
health issues and are under chronic stress conditions, which
might weaken the immune response to vaccination (41), such as
to the combined vaccination with Gonacon and rabies vaccines.
Therefore, although some adjustments were needed in order to
perform a study with feral cats as compared to well-maintained
friendly cats (in regards to capturing, management, handling,
cet.), the study was designed to examine the short term safety
and efficacy of our combined vaccination approach specifically
in feral queens, as they are the main target population for
non-surgical contraception/sterilization.
Accordingly, in our study, the feral queens were captured by
traps, and were maintained under ambient summer temperature
and light. The study was conducted during the Israeli
summer to avoid suppressing effects of the photoperiod or
climate conditions on the reproductive system (8, 21, 53, 54).
Furthermore, queens were vaccinated 24–72 h after they were
captured, while their health condition was still typical to that
of feral cats. Indeed, our physical examination and blood tests
performed at study initiation, just prior to vaccination, indicated
that many of the queens were in suboptimal body condition,
and some had signs of anemia, inflammation, or muscle injuries.
Furthermore, many cats had a high eosinophilic count in
their blood, suggesting high infestation of gastrointestinal or
other parasites. Despite the suboptimal health condition of the
feral cats in the current study, the combined vaccination with
Gonacon and rabies was safe and effective in the short term.
None of the animals showed any local or systemic adverse
reactions. In the study of Levy et al. (31), late-onset (2 years
post-treatment) granulomatous injection-site masses developed
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FIGURE 6 | Serum GnRH antibodies titer of individual cats vaccinated with Gonacon. Each graph represents data of a single cat. GonaconX1-Rabies group: cats
vaccinated once with both Gonacon and rabies (n = 5; light blue); GonaconX2-Rabies group: cats vaccinated twice with Gonacon (3 weeks apart) and once with
rabies (n = 4; dark blue); Blood samples were collected every 2 weeks for a total of 14 weeks. Note the reduction of antibodies in cat#4 at weeks 12 and 14, as well
as the non-responder cats (#9) in the GonaconX2-Rabies group.
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FIGURE 7 | Serum rabies antibodies of cats in the research groups. Mean ±
SEM rabies antibodies concentrations are presented for each group:
GonaconX1-Rabies: cats vaccinated with both Gonacon and rabies (n = 5);
GonaconX2-Rabies: cats vaccinated twice with Gonacon (3 weeks apart) and
with rabies (n = 4); OVx-Rabies: cats ovariohysterectomized and vaccinated
with rabies (n = 4); Intact-Rabies: cats vaccinated against rabies and remained
intact (n = 3). Blood samples were collected every 2 weeks for a total of 14
weeks. There were no significant differences in the rabies antibodies among
the groups (p = 0.3169), or group X time interaction (p = 0.7220); however,
the time was a significant factor (Repeated measure ANOVA, p < 0.0001).
Dotted lines indicate protective titer (>0.5 IU/mL).
in 5/15 (33%) of the Gonacon-vaccinated female cats. However,
in another study conducted by the same group, no injection site
masses were detected in male cats at a period of 6 months post-
injection (30). In the study conducted by Vansandt et al. (32),
four cats developed a sterile, painless, self-limiting mass at the
site of Gonacon injection, after only few weeks. Fisher et al.
(33) reported injection-site reactions ranging from swelling to
transient granulomatous masses in 45% (n = 9/20) of vaccinated
cats, beginning at least 1 month after treatment. Furthermore,
in another study conducted in our laboratory (Novak and Raz,
unpublished data), we also documented injection-site masses 3
to 12 months post-Gonacon vaccination in 7/44 (16%) owner-
owned cats. Therefore, it is possible that in the current study,
masses were not detected at all as the monitoring period of
14 weeks was relatively short; furthermore, we cannot rule out
the possibility of local reactions later on, after the queens were
released back to their environment or adopted. Regarding the
systemic health conditions of the queens, although it was initially
suboptimal for many of the animals, as typical for feral cats in
Israel and other places, it improved over the study period. This
improvement in the cats’ health is probably due to the housing
conditions during the study which allow the queens to recover;
i.e., good availability of food, water, and shelter; reduced risks of
infectious diseases and injuries; as well as reduced stress due to
the acclimation of the cats to their environment.
Despite the initial suboptimal health condition of the feral
cats in the current study, the combined vaccination with
Gonacon and rabies was effective in the short term. Following
vaccination with rabies, all queens from all the groups produced
antibodies against rabies, which remained above the level
considered protective. Bender et al. (29) vaccinated dogs with
both Gonacon and a commercial rabies vaccine (Defensor 3,
Pfizer, Inc., New York, NY, USA), and reported no adverse
effects of simultaneous vaccination on rabies virus neutralizing
antibody production. None of the previous studies measured
rabies antibodies in Gonacon-vaccinated cats, even if cats were
vaccinated with both vaccines (32, 33). Nevertheless, our results
support our hypothesis that antibody titers against rabies will
not be negatively influenced by the simultaneous vaccination
approach and will remain protective during the study period.
Following vaccination with Gonacon, anti-GnRH antibodies
titer increased in all vaccinated queens within 2–4 weeks,
except for one non-responder queen from the GonaconX2-
Rabies group. In all responder queens, anti-GnRH titer remained
high during the study period, except for one queen from
the GonaconX1-Rabies group, in which it reduced in the
last two examinations. This queen was identified as FIV
positive, which could have affected the immunogenicity of
the Gonacon vaccine; however, the production of anti-rabies
antibodies did not appear to be negatively affected in this queen.
Nevertheless, the possibility of immunogenicity alteration of any
immunocontraception vaccine due to FIV infection is interesting
and warrants further investigation, as FIV might be quite
prevalent among free-roaming cat populations (35, 55–57). There
was no significant difference in GnRH antibodies between the
GonaconX1-Rabies and GonaconX2-Rabies groups. However, as
our study focused on the short-term effects, we cannot rule
out the possibility that repeated Gonacon vaccinations would
extend the effective period, and potentially provide extended
contraception. Furthermore, as our assay was limited to series
dilutions from 1:8,000 to 1:64,000, it is possible that the double
Gonacon vaccination could have shown positive results in higher
dilutions than 1:64,000. Previous studies showed that some cats
did not respond to the Gonacon vaccine (i.e., no anti-GnRH
antibodies), while others responded to the vaccine with anti-
GnRH antibodies detected for various periods after injection. The
only other study which compared a single to double Gonacon
vaccination could not detect differences in the anti-GnRH
antibody at 1:1,024 dilution at 4-month post-vaccination of
ovariectomized queens (3 cats in each group) (32). Nevertheless,
our hypothesis that two doses of Gonacon would induce higher
anti-GnRH titer, as compared to a single vaccination, require
further long-term study.
There are several relevant approaches to evaluate the function
of the reproductive system following the administration of
an immunocontraceptive agent, but it is clear that breeding
provides the most definitive results. However, breeding trials,
particularly in overpopulated species like cats, are practically
challenging, require time and resources, as well as carry
some ethical dilemmas, as to the destiny of the newborn
offspring (or performing ovariohysterectomy of pregnant
animals). Therefore, in the current study, we were looking
for other alternatives. Accordingly, we evaluated the effects
of Gonacon vaccination on the reproductive system by a
combination of serum AMH concentrations measurements,
vaginal cytology, and ovarian histology; which all suggested
that the reproductive cyclicity was indeed suppressed in
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FIGURE 8 | Serum concentrations of anti-müllerian hormone of cats in the research groups. Serum concentrations of anti-müllerian hormone (Mean ± SEM) are
presented for each group: GonaconX1-Rabies: cats vaccinated with both Gonacon and rabies (n = 5); GonaconX2-Rabies: cats vaccinated twice with Gonacon
(3 weeks apart) and with rabies (n = 4); OVx-Rabies: cats ovariohysterectomized and vaccinated with rabies (n = 4); Intact-Rabies: cats vaccinated against rabies and
remained intact (n = 3). Analyses were performed on blood samples collected at 0, 8, and 14 weeks after the initial vaccination. a,bDifferent letters above bars
represent significant differences (p < 0.0.5).
Gonacon-vaccinated queens. In females, AMH is a hormone
produced in the ovaries by small and developing follicles,
and has a pivotal role in the regulation of ovarian follicle
reserve and folliculogenesis. Studies in other species have shown
that there is a correlation between the number of developing
follicles in the ovary and serum AMH concentration (58).
It has also been found that when a queen is spayed, AMH
serum concentration drops abruptly (50, 59). Accordingly,
we initially hypothesized that AMH serum concentrations
would be reduced following ovariohysterectomy, as well as
following vaccination with Gonacon, due to the vaccine potential
suppression effect on gonadotropins and folliculogenesis. Indeed,
in the current study, AMH serum concentration was extremely
low following ovariohysterectomies, but it remained high in
intact queens, in agreement with previous studies in cats and
other species (50, 59, 60). Interestingly, in queens vaccinated
with Gonacon, the reduction in AMH concentration was gradual.
Eventually, at study completion, AMH serum concentrations
were lower in all Gonacon-vaccinated queens, as compared
to study initiation, except in the non-responder queen from
the GonaconX2-Rabies group, in which AMH concentrations
remained stable throughout the study. Furthermore, statistical
analysis of all serum samples obtained from Gonacon-vaccinated
queen revealed that AMH concentrations were significantly
lower in serum samples with high anti-GnRH titers (titer
0, 6.7 ± 1.1 ng/mL, vs. titer 1:64, 3.9 ± 0.7 ng/mL; p =
0.0429). Overall, these findings suggest, for the first time
to the best of our knowledge, that measuring AMH serum
concentration is a valuable method for evaluating the efficacy
of immunocontraception.
Evaluation of vaginal cytology smears and histology of the
ovaries at study completion indicated that none of the Gonacon-
vaccinated queens was in estrus, except the non-responder
queen. However, the assessment of these results, particularly
those of the vaginal cytology, could have been clearer if other
analyses could have done, such as measurements of other sexual
hormones (e.g., estrogen, LH, and FSH), and ultrasonography
of the reproductive tract. Nevertheless, the typical histological
finding in the ovaries of Gonacon-vaccinated queens was the
presence of a high number of degenerated oocytes, and lack
of antral follicles, alongside a low percentage of superficial
cells in vaginal smears. In contrast, in intact animals (samples
of the Ovx-Rabies group just before spaying; and samples of
Intact-Rabies at study completion), ovaries had normal histology,
with various follicles (primary, secondary, and antral follicle),
and very few degenerative oocytes. Interestingly, the ovaries of
the non-responder queen from the GonaconX2-Rabies group
were histologically similar to those of the controls, and the
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FIGURE 9 | Histology of ovaries of Gonacon-vaccinated cats. Representative ovaries of Gonacon-vaccinated cats (A) are shown, as compared to ovaries of
non-vaccinated cats (B). Note the large number of degenerative oocytes (black arrows) in the ovaries of Gonacon-vaccinated cats. PF, crowded primordial follicles
under the ovary’s tunica albuginea, at the ovarian cortex; F, antral follicles. H&E staining. Scale bars in all images are 30µm.
vaginal cytology smear had a high number of superficial cells
(∼90%) indicated that this female was in estrus. In our histologic
evaluation, we were not able to detect apparent differences in
the primordial follicle reserve in the ovaries, nor differences in
the endometrium. Future studies should consider exploring the
possible short and long-term effects of immunocontraceptive
agents on the primordial follicle reserve, as the reduction
or elimination of this pool would be beneficial for long-
term contraception/sterilization.
Out of the three previous publications regarding Gonacon
vaccination in female cats, two studies examined the
contraceptive effect. In the long-term study conducted by
Levy et al. (31), 15 queens were vaccinated with the early
generation Gonacon vaccine, and were exposed to intact males.
Gonacon-vaccinated queens re-gained fertility at a later time, as
compared to controls; of the 15 vaccinated queens, 93% were
infertile for at least 1 year, 73% for 2 years, 53% for 3 years, and
40% for 4 years; 27% were still infertile at the conclusion of the
5-year study. In the study conducted by Vansandt et al. (32),
ovariectomized queens were used, and therefore, the possible
effects of Gonacon vaccination on the reproductive system could
not be determined. Later on, Fischer et al. (33) reported poor
contraceptive efficacy of the Gonacon vaccine in colony cats.
In their study, queens were exposed to intact males 4 months
after vaccination with the newer Gonacon version. All control
queens (n= 10/10) and 60% (n= 12/20) of Gonacon-vaccinated
queens became pregnant within 4 months of the introduction
of males. Two additional vaccinated queens became pregnant
(70%; n = 14/20) within 1 year of treatment. Overall, vaccinated
queens had a significantly longer (P = 0.0120) median time to
conception (212 days), and lower fetal counts. Nevertheless, the
results of their study were disappointing. In the current study,
which utilized the same Gonacon formulation as in the study of
Fischer et al. (33) but of different batch, our approach indicated
that ovarian cyclicity was suppressed in all queens who respond
to the Gonacon vaccine, as detailed above. The differences
among studies could be due to variability in the vaccine itself
[overtime differences in formulas, as reviewed by Benka et al.
(15); different batches]; differences between cats (laboratory vs.
free-roaming vs. stray cats); environmental conditions; as well as
individual variability.
There are several limitations to our study. It is possible that
due to the small number of cats in each of the groups, as well
as the short duration of the study, we were not able to detect
uncommon adverse reactions, or other safety issues, that could
have been detected in a large group of vaccinated cats or at a
later stage. Also, the validity of the vaccines’ immunogenicity
and the assessment of the proportion of non-responder cats
(i.e., no antibody formation), as well as the assessment of
reproductive effects, based on a small number of vaccinated
cats examined over a short period, is limited. In regards to
the assessment of the cats’ health before and after vaccination,
future studies should consider performing additional lab tests,
such as urinalysis and fecal examination for the detection of
intestinal parasites, which were not performed in our study, and
could have provided a better understanding of the cat health
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status at vaccination. In regards to reproductive effects, other
methods, such as assessment of other sexual hormones (e.g.,
estrogen, LH, FSH), ultrasonography of the reproductive tract,
and breeding, should be considered and combined. In addition,
during our study period, the queens were housed in individual
cages, in conditions that were not similar to that of feral cats
in an urban environment. Our study emphasizes the need to
explore the safety and efficacy of the Gonacon vaccine in several
target populations, and we therefore believe that further long-
term studies are warranted, including in populations of stray
cats in their natural environment, as well as in pet indoor vs.
outdoor cats.
In summary, to the best of our knowledge, this is the
first study that examined the short-term safety and efficacy
of combined vaccination approach, which included anti-GnRH
vaccine (Gonacon), given either as a single dose, or as two doses
3 weeks apart, in parallel with rabies vaccine, specifically in female
feral cats. Overall, our results indicate that in the short term,
the combined vaccination with Gonacon and rabies is safe and
effective in female feral cats, with no apparent benefits for two
Gonacon vaccinations as compared to a single dose. Following
the combined vaccination, anti-GnRH and rabies antibodies were
detected, despite the suboptimal health condition of the queens.
Furthermore, evaluation of serum AMH concentrations, vaginal
cytology, and ovarian histology suggested that reproductive
cyclicity was indeed suppressed in Gonacon-vaccinated queens
for at least 3 months. However, future studies should examine the
long-term effects of contraceptive agents in free-roaming cats in
their natural environment.
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